Treatment & Prognosis of Mast Cell Tumors

Removal of mast cell tumors through surgery is the treatment of choice when possible. Antihistamines may be given prior to surgery to protect against the effects of histamine released from the tumor. Wide margins of approximately up to 1 inch (3 centimeters) are required depending on the grade because of the tendency for the tumor cells to spread beyond the margins of the tumor.

Mast cell tumors that are Grade I or II that can be completely removed have a good prognosis without additional treatment. One study showed that about 23% of incompletely removed Grade II tumors recurred locally. Tumors that have spread to the lymph nodes or other parts of the body have a poor prognosis. Any dog showing symptoms of mastocytosis or with a Grade III tumor has a poor prognosis. Kinavet-CA1® brings a cutting-edge new technology to the treatment of mast cell tumors, in an easy to administer, single daily oral dose. Because of the unique action of Kinavet-CA1® against mast cells, it is now possible to directly target the cells responsible for proliferation of this potentially aggressive tumor. Thus, Kinavet-CA1® is an invaluable solution to directly address the origin, thereby obtaining great efficacy against the tumor and potential metastases and to protect against future tumor recurrence.
​